Patients who suffer from serious and fatal illnesses may be granted early access to drugs that are still in the experimental stage. By clarifying the rules for granting patients access to the so-called investigational drugs, U.S. health officials said this week that they hope to be able to expand the number of people who might benefit from these medications that are not yet approved.